Searched for
BLUEROCK THERAPEUTICS
Breakthrough in China: Stem cell therapy achieves efficiency in Parkinson's recoveryChinese scientists have developed a groundbreaking stem cell therapy for Parkinson's disease. Their treatment serves an impressive self-pro...- Bayer’s gene and cell therapy pipeline aims to transform Parkinson’s, oncology, rare diseases and moreBayer, through its subsidiary Viralgen, is advancing cell and gene therapies (CGT) to cure diseases like Parkinson's, oncology, cardiovascu...
- Bayer to acquire Asklepios Bio in foray into gene therapy worth up to $4 billionGermany’s Bayer will pay $2 billion upfront and up to an additional $2 billion in milestone payments contingent on development achievements...
- Biotech startups choosy on deals with big pharma: Bayer executiveRegulatory and clinical development expertise and the might to take products through the commercialization stages offer a natural edge to b...
Load More